JPRN-UMIN000008368已完成2 期
Adjuvant Chemotherapy for Endometrial cancer Trial: A randomised phase II study of TEC, TAC and ddTC for endometrial carcinoma - ACE trial
Gynecologic Oncology Group of Osaka (GOGO)0 个研究点目标入组 90 人开始时间: 2012年9月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1)Patients with sarcomatous element 2)Active infections 3)Serious complications (heart disease, uncontrolled diabetes mellitus, malignant hypertension and tendency to bleeding) 4)Active concomitant malignancy 5)Interstitial pneumonitis and plumonary fibrosis 6)Massive pleural effusion or ascites 7)Neuropathy grade 2 or more (NCI-CTC) 8)Edema grade 2 or more (NCI-CTC) 9)prior chemotherapy including doxorubicin 10)Hypersensitivity to Polysorbate 80 or Cremophor EL 11)patients who are pregnant, lactating, possibly pregnant, or planning to become pregnant 12)Patients judged inappropriate for this study by the physicians
研究者
相似试验
招募中
1 期
Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials – p53abn - REDRandomized phase III trial testing maintenance olaparib versus observation after adjuvant chemoradiation for p53abn endometrial cancerPatients with a histological diagnosis of p53abn HREC, treated with curative intent, after surgery (hysterectomy and bilateral salpingooophorectomy, with or without lymphadenectomy or sentinel node biopsy), without signs of residual disease or distant metastasesCTIS2023-503886-44-00Institut Gustave Roussy150
尚未招募
3 期
Study of additional treatment after surgery in endometrial cancerCTRI/2024/08/072343eiden University Medical Center
撤回
3 期
Chemotherapy Adjuvant Study for women at advanced Age (CASA); Phase III Trial Evaluating the Role of Adjuvant Pegylated Liposomal Doxorubicin (PLD, Caelyx®, Doxil®) for Women (age 66 years or older) with Endocrine Nonresponsive Breast Cancer Who Are NOT Suitable for Being Offered a *Standard Chemotherapy Regimen*breast cancerNL-OMON31071International Breast Cancer Study Group (IBCSG)35
已完成
3 期
IBCSG VII - Adjuvant chemotherapy in node positive postmenopausal breast cancer patients: endocrine vs. chemo-endocrine vs. chemo-endocrine with delayed chemotherapy.Cancer - BreastBreast CancerACTRN12607000023459International Breast Cancer Study Group1,200
已完成
2 期
eo-adjuvant chemotherapy, cytoreductive surgery with hypethermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin.peritoneal cancerperitoneal carcinomatosis100346521001799110017998NL-OMON38114niversitair Medisch Centrum Groningen50